Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
CTSO
CTSO
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
CTSO News
Virtual Investor Conferences Forum Highlights
Jun 26 2026
Globenewswire
Agenda Announced for Life Sciences Virtual Investor Forum
Jun 23 2026
Globenewswire
Cytosorbents Q1 2026 Earnings Call Insights
May 14 2026
seekingalpha
Cytosorbents Q1 Earnings Report Analysis
May 13 2026
seekingalpha
Cytosorbents to Announce Q1 Earnings on May 13
May 12 2026
seekingalpha
CytoSorbents Reports 4% Revenue Growth in 2025
Mar 26 2026
Yahoo Finance
Cytosorbents Q4 2025 Earnings Call Insights
Mar 25 2026
seekingalpha
Cytosorbents Reports Q4 and Full Year 2025 Financial Results
Mar 25 2026
seekingalpha
Cytosorbents to Announce Q4 Earnings on March 25
Mar 24 2026
seekingalpha
CytoSorbents Launches HotSwap™ to Optimize Critical Care Treatment
Mar 19 2026
Newsfilter
CytoSorbents Launches HotSwap™ to Optimize Critical Care Therapy
Mar 19 2026
PRnewswire
CytoSorbents Announces Q4 and Full Year 2025 Earnings Release Date
Mar 05 2026
PRnewswire
CytoSorbents (CTSO) Projects $37M Revenue for 2025, FDA Meeting Scheduled
Jan 12 2026
PRnewswire
CytoSorbents Reports $37M in Q3 Sales; CEO to Join Virtual Discussion
Dec 10 2025
PRnewswire
Updated: CytoSorbents to Present at the Jefferies Global Healthcare Conference in London
Nov 17 2025
PRnewswire
HC Wainwright & Co. Upholds Neutral Rating for Cytosorbents (CTSO)
Nov 15 2025
NASDAQ.COM
Show More News
